187 related articles for article (PubMed ID: 24032553)
1. Long-term anti-FVIII antibody response in Bethesda-negative haemophilia A patients receiving continuous replacement therapy.
Klintman J; Hillarp A; Berntorp E; Astermark J
Br J Haematol; 2013 Nov; 163(3):385-92. PubMed ID: 24032553
[TBL] [Abstract][Full Text] [Related]
2. Antibody formation and specificity in Bethesda-negative brother pairs with haemophilia A.
Klintman J; Hillarp A; Donfield S; Berntorp E; Astermark J
Haemophilia; 2013 Jan; 19(1):106-12. PubMed ID: 22762454
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of nonneutralizing antibodies against factor VIII in severe haemophilia A patients from India.
David S; Mathews NS; Singh GS; Korula A; Aboobacker FN; Abraham A; George B; Srivastava A; Mathews V; Nair SC
Blood Coagul Fibrinolysis; 2019 Oct; 30(7):337-340. PubMed ID: 31449137
[TBL] [Abstract][Full Text] [Related]
4. Thrombin generation as objective parameter of treatment response in patients with severe haemophilia A and high-titre inhibitors.
Luna-Záizar H; Beltrán-Miranda CP; Esparza-Flores MA; Soto-Padilla J; Bergés-García A; Rodríguez-Zepeda MD; Pompa-Garza MT; Jaloma-Cruz AR
Haemophilia; 2014 Jan; 20(1):e7-14. PubMed ID: 24354488
[TBL] [Abstract][Full Text] [Related]
5. Comparative measurement of anti-factor VIII antibody by Bethesda assay and ELISA reveals restricted isotype profile and epitope specificity.
Towfighi F; Gharagozlou S; Sharifian RA; Kazemnejad A; Esmailzadeh K; Managhchi MR; Shokri F
Acta Haematol; 2005; 114(2):84-90. PubMed ID: 16103630
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and epitope specificity of non-neutralising antibodies in a large cohort of haemophilia A patients without inhibitors.
Lebreton A; Lapalud P; Chambost H; Biron-Andréani C; Morange PE; Combescure C; Marquès-Verdier A; Berger C; Schved JF; Granier C; Lavigne-Lissalde G
Thromb Haemost; 2011 Jun; 105(6):954-61. PubMed ID: 21475776
[TBL] [Abstract][Full Text] [Related]
7. Analysis of F8 inversions as risk factors for FVIII inhibitor development in Indian severe haemophilia A patients.
Pinto P; Ghosh K; Shetty S
Blood Cells Mol Dis; 2014 Sep; 53(3):161-3. PubMed ID: 24824129
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic accuracy study of a factor VIII ELISA for detection of factor VIII antibodies in congenital and acquired haemophilia A.
Batty P; Moore GW; Platton S; Maloney JC; Palmer B; Bowles L; Pasi KJ; Rangarajan S; Hart DP
Thromb Haemost; 2015 Oct; 114(4):804-11. PubMed ID: 26063073
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and Incidence of Non-neutralizing Antibodies in Congenital Hemophilia A- A Systematic Review and Meta-Analysis.
Abdi A; Bordbar MR; Hassan S; Rosendaal FR; van der Bom JG; Voorberg J; Fijnvandraat K; Gouw SC
Front Immunol; 2020; 11():563. PubMed ID: 32457734
[No Abstract] [Full Text] [Related]
10. Antifactor VIII antibody inhibiting allogeneic but not autologous factor VIII in patients with mild hemophilia A.
Peerlinck K; Jacquemin MG; Arnout J; Hoylaerts MF; Gilles JG; Lavend'homme R; Johnson KM; Freson K; Scandella D; Saint-Remy JM; Vermylen J
Blood; 1999 Apr; 93(7):2267-73. PubMed ID: 10090936
[TBL] [Abstract][Full Text] [Related]
11. Alloantibodies to factor VIII in haemophilia.
Zakarija A; Harris S; Rademaker AW; Brewer J; Krudysz-Amblo J; Butenas S; Mann KG; Green D
Haemophilia; 2011 Jul; 17(4):636-40. PubMed ID: 21299745
[TBL] [Abstract][Full Text] [Related]
12. Combined administration of FVIII and rFVIIa improves haemostasis in haemophilia A patients with high-responding inhibitors--a thrombin generation-guided pilot study.
Livnat T; Martinowitz U; Azar-Avivi S; Zivelin A; Brutman-Barazani T; Lubetsky A; Kenet G
Haemophilia; 2013 Sep; 19(5):782-9. PubMed ID: 23659442
[TBL] [Abstract][Full Text] [Related]
13. Different factor VIII neutralizing effects on anti-factor VIII inhibitor antibodies associated with epitope specificity and von Willebrand factor.
Yada K; Nogami K; Shima M
Br J Haematol; 2013 Oct; 163(1):104-11. PubMed ID: 23889549
[TBL] [Abstract][Full Text] [Related]
14. Epitope specificity of anti-factor VIII antibodies from inhibitor positive acquired and congenital haemophilia A patients using synthetic peptides spanning A and C domains.
Gharagozlou S; Sharifian RA; Khoshnoodi J; Karimi K; Milani M; Okita DK; Shokri F; Conti-Fine BM
Thromb Haemost; 2009 May; 101(5):834-9. PubMed ID: 19404535
[TBL] [Abstract][Full Text] [Related]
15. Immunoglobulin isotypes and functional anti-FVIII antibodies in response to FVIII treatment in Balb/c and C57BL/6 haemophilia A mice.
Qadura M; Waters B; Burnett E; Chegeni R; Hough C; Othman M; Lillicrap D
Haemophilia; 2011 Mar; 17(2):288-95. PubMed ID: 21091850
[TBL] [Abstract][Full Text] [Related]
16. [Characterization of factor VIII antibody epitopes from haemophilia A patients using cellulose bound FVIII peptide libraries].
Albert T; Lange S; Oldenburg J; Graw J; Schramm W; Hanfland P; Brackmann HH; Schwaab R
Hamostaseologie; 2003 Feb; 23(1):13-7. PubMed ID: 12567194
[TBL] [Abstract][Full Text] [Related]
17. Von Willebrand factor modulates factor VIII immunogenicity: comparative study of different factor VIII concentrates in a haemophilia A mouse model.
Behrmann M; Pasi J; Saint-Remy JM; Kotitschke R; Kloft M
Thromb Haemost; 2002 Aug; 88(2):221-9. PubMed ID: 12195693
[TBL] [Abstract][Full Text] [Related]
18. Inhibitors in hemophilia A: mechanisms of inhibition, management and perspectives.
Ananyeva NM; Lacroix-Desmazes S; Hauser CA; Shima M; Ovanesov MV; Khrenov AV; Saenko EL
Blood Coagul Fibrinolysis; 2004 Mar; 15(2):109-24. PubMed ID: 15090997
[TBL] [Abstract][Full Text] [Related]
19. A longitudinal evaluation of anti-FVIII antibodies demonstrated IgG4 subclass is mainly correlated with high-titre inhibitor in haemophilia A patients.
Montalvão SA; Tucunduva AC; Siqueira LH; Sambo AL; Medina SS; Ozelo MC
Haemophilia; 2015 Sep; 21(5):686-92. PubMed ID: 25708525
[TBL] [Abstract][Full Text] [Related]
20. In silico calculated affinity of FVIII-derived peptides for HLA class II alleles predicts inhibitor development in haemophilia A patients with missense mutations in the F8 gene.
Pashov AD; Calvez T; Gilardin L; Maillère B; Repessé Y; Oldenburg J; Pavlova A; Kaveri SV; Lacroix-Desmazes S
Haemophilia; 2014 Mar; 20(2):176-84. PubMed ID: 24118514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
